Zevra Therapeutics (ZVRA) Financials: Revenue & Earnings
$603.10M
Market Cap
—
P/E
—
Forward P/E
—
Score
ZVRA price $10.16 +0.10 +1.00%
ZVRA fair value $38.44. Price $10.16. Price is 74% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | 0.14 | — | 37.08M |
| 2026-08-05 | 0.14 | 0.11 | 39.66M | 33.88M |
| 2026-05-06 | 0.60 | 0.06 | 36.22M | 31.96M |
| 2026-03-09 | 0.21 | 0.05 | 34.10M | 28.05M |
| 2025-11-05 | -0.01 | -0.02 | 26.06M | 26.64M |
| 2025-08-12 | 1.21 | 2.19 | 25.88M | 24.52M |
| 2025-05-13 | -0.06 | -0.21 | 20.40M | 21.07M |
| 2025-03-11 | -0.67 | -0.39 | 12.04M | 16.66M |
| 2024-11-12 | -0.69 | -0.44 | 3.69M | 8.78M |
| 2024-08-13 | -0.48 | -0.47 | 4.45M | 4.36M |
| 2024-05-08 | -0.40 | -0.49 | 3.42M | 4.65M |
| 2024-03-28 | -0.40 | -0.20 | 13.22M | 11.74M |
| 2023-11-07 | -0.40 | -0.29 | 2.90M | 10.95M |
| 2023-08-14 | -0.15 | -0.39 | 8.47M | 3.03M |
| 2023-05-15 | -0.34 | -0.26 | 2.88M | 2.65M |
| 2023-03-07 | -0.26 | -0.21 | 2.32M | 3.11M |
| 2022-11-09 | -0.19 | -0.13 | 2.87M | 3.01M |
| 2022-08-11 | -0.70 | -0.12 | 1.30M | 1.75M |
| 2022-05-12 | -0.05 | -0.05 | 3.96M | 3.06M |
| 2022-03-30 | -0.08 | -0.07 | 2.58M | 2.23M |
| 2021-11-10 | -0.05 | -0.07 | 1.97M | — |
| 2021-08-12 | 0.21 | 0.23 | 11.99M | — |
| 2021-05-13 | -0.54 | -0.17 | 12.12M | — |
| 2021-03-11 | -1.07 | -0.64 | 2.37M | — |
| 2020-10-29 | -0.64 | -0.80 | 1.93M | — |
| 2020-08-12 | 0.16 | — | 6.91M | — |
| 2020-05-12 | -1.76 | 0.16 | 2.09M | — |
| 2020-02-28 | -0.16 | -1.36 | 1.38M | — |
| 2019-11-14 | 0.96 | -2.99 | 11.46M | — |
| 2019-08-13 | -5.28 | -6.80 | — | — |
| 2019-05-14 | -7.36 | -7.36 | — | — |
| 2019-02-28 | -3.20 | -8.44 | — | — |
| 2018-11-08 | -15.04 | -12.32 | — | — |
| 2018-08-09 | -14.56 | -15.42 | — | — |
| 2018-05-10 | -28.32 | -11.16 | — | — |
| 2018-03-29 | -11.52 | -10.96 | — | — |
| 2017-11-09 | -10.88 | -10.76 | — | — |
| 2017-08-10 | -7.04 | -10.08 | — | — |
| 2017-05-10 | -13.44 | -10.08 | — | — |
| 2017-03-09 | -10.88 | -11.15 | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-12 | McFarlane Neil F. | Sell | 20.00K | $11.25 | 224.95K |
| 2026-10-10 | McFarlane Neil F. | Buy | 50.00K | — | — |
| 2026-10-10 | McFarlane Neil F. | Sell | 50.00K | — | — |
| 2026-08-14 | Thompson Rahsaan | Sell | 42.67K | $11.13 | 474.77K |
| 2026-08-10 | Watton Corey Michael | Sell | 12.30K | $4.97 | 61.13K |
| 2026-08-10 | Watton Corey Michael | Buy | 12.30K | $4.97 | 61.13K |
| 2026-08-10 | Watton Corey Michael | Sell | 12.30K | $11.25 | 138.38K |
| 2026-06-22 | Thompson Rahsaan | Sell | 34.56K | $12.68 | 438.30K |
| 2026-06-21 | Thompson Rahsaan | Buy | 66.67K | — | — |
| 2026-06-21 | Thompson Rahsaan | Sell | 66.67K | — | — |
| 2026-06-04 | FAVORITO TAMARA A | Buy | 30.00K | $11.17 | 335.10K |
| 2026-06-04 | Secor Alicia | Buy | 30.00K | $11.17 | 335.10K |
| 2026-06-04 | Watton Corey Michael | Buy | 30.00K | $11.17 | 335.10K |
| 2026-06-04 | Calder Douglas W | Buy | 30.00K | $11.17 | 335.10K |
| 2026-06-04 | Anderson Thomas | Buy | 30.00K | $11.17 | 335.10K |
| 2026-06-04 | Shih Alvin | Buy | 30.00K | $11.17 | 335.10K |
| 2026-05-28 | Sangiovanni Timothy J. | Buy | 40.00K | $11.40 | 456.00K |
| 2026-05-28 | Sangiovanni Timothy J. | Buy | 20.00K | — | — |
| 2026-05-11 | Thompson Rahsaan | Sell | 1.79K | $11.30 | 20.27K |
| 2026-03-24 | Bode John B | Buy | 39.20K | $4.89 | 191.69K |
| 2026-03-24 | Bode John B | Buy | 39.20K | $4.97 | 194.82K |
| 2026-03-24 | Bode John B | Sell | 39.20K | $4.97 | 194.82K |
| 2026-03-24 | Bode John B | Sell | 39.20K | $4.89 | 191.69K |
| 2026-03-18 | Renz Justin A | Buy | 300.00K | $9.55 | 2.87M |
| 2026-03-18 | Renz Justin A | Other | 0 | — | — |
| 2026-02-09 | McFarlane Neil F. | Sell | 14.62K | $8.56 | 125.19K |
| 2026-02-07 | McFarlane Neil F. | Buy | 37.50K | — | — |
| 2026-02-07 | McFarlane Neil F. | Sell | 37.50K | — | — |
| 2026-02-03 | Sangiovanni Timothy J. | Sell | 3.00K | $9.18 | 27.55K |
| 2026-02-03 | Schafer Joshua | Sell | 10.50K | $9.19 | 96.50K |
| 2026-02-02 | McFarlane Neil F. | Sell | 91.00K | $9.38 | 853.43K |
| 2026-01-31 | Sangiovanni Timothy J. | Buy | 11.67K | — | — |
| 2026-01-31 | Sangiovanni Timothy J. | Sell | 11.67K | — | — |
| 2026-01-31 | Schafer Joshua | Buy | 35.33K | — | — |
| 2026-01-31 | Schafer Joshua | Sell | 35.33K | — | — |
| 2026-01-31 | McFarlane Neil F. | Buy | 233.33K | — | — |
| 2026-01-31 | McFarlane Neil F. | Sell | 233.33K | — | — |
| 2026-01-30 | Sangiovanni Timothy J. | Buy | 6.33K | — | — |
| 2026-01-30 | Sangiovanni Timothy J. | Sell | 1.75K | $8.82 | 15.44K |
| 2026-01-30 | Sangiovanni Timothy J. | Sell | 6.33K | — | — |
| 2026-01-30 | Thompson Rahsaan | Buy | 11.33K | — | — |
| 2026-01-30 | Thompson Rahsaan | Sell | 4.08K | $8.83 | 36.01K |
| 2026-01-30 | Thompson Rahsaan | Sell | 11.33K | — | — |
| 2026-01-30 | Quartel Adrian W | Sell | 11.33K | — | — |
| 2026-01-30 | Quartel Adrian W | Buy | 11.33K | — | — |
| 2026-01-30 | Quartel Adrian W | Sell | 4.53K | $8.83 | 40.04K |
| 2026-01-30 | Schafer Joshua | Buy | 11.33K | — | — |
| 2026-01-30 | Schafer Joshua | Sell | 3.38K | $8.83 | 29.80K |
| 2026-01-30 | Schafer Joshua | Sell | 11.33K | — | — |
| 2026-01-29 | Thompson Rahsaan | Buy | 75.00K | $8.86 | 664.50K |
| 2026-01-29 | Thompson Rahsaan | Buy | 37.50K | — | — |
| 2026-01-29 | Quartel Adrian W | Buy | 75.00K | $8.86 | 664.50K |
| 2026-01-29 | Quartel Adrian W | Buy | 37.50K | — | — |
| 2026-01-29 | Schafer Joshua | Buy | 75.00K | $8.86 | 664.50K |
| 2026-01-29 | Schafer Joshua | Buy | 37.50K | — | — |
| 2026-01-29 | McFarlane Neil F. | Buy | 250.00K | $8.86 | 2.21M |
| 2026-01-29 | McFarlane Neil F. | Buy | 125.00K | — | — |
| 2025-12-31 | Clifton R. LaDuane | Buy | 140.67K | — | — |
| 2025-12-31 | Clifton R. LaDuane | Sell | 48.51K | $8.96 | 434.68K |
| 2025-12-31 | Clifton R. LaDuane | Sell | 20.00K | — | — |
| 2025-12-31 | Clifton R. LaDuane | Sell | 34.00K | — | — |
| 2025-12-02 | Secor Alicia | Buy | 45.00K | $8.17 | 367.65K |
| 2025-12-02 | Secor Alicia | Other | 0 | — | — |
| 2025-10-10 | McFarlane Neil F. | Buy | 50.00K | — | — |
| 2025-10-10 | McFarlane Neil F. | Sell | 19.50K | $10.82 | 210.91K |
| 2025-10-10 | McFarlane Neil F. | Sell | 50.00K | — | — |
| 2025-09-12 | FAVORITO TAMARA A | Buy | 3.17K | $7.79 | 24.72K |
| 2025-09-12 | Shih Alvin | Buy | 20.00K | $7.89 | 157.80K |
| 2025-08-19 | Bode John B | Buy | 5.00K | $9.16 | 45.82K |
| 2025-06-26 | Thompson Rahsaan | Sell | 24.00K | $9.21 | 221.00K |
| 2025-06-21 | Thompson Rahsaan | Sell | 66.67K | — | — |
| 2025-06-21 | Thompson Rahsaan | Buy | 66.67K | — | — |
| 2025-05-29 | Shih Alvin | Buy | 30.00K | $8.62 | 258.60K |
| 2025-05-29 | DIXON WENDY L | Buy | 30.00K | $8.62 | 258.60K |
| 2025-05-29 | Calder Douglas W | Buy | 30.00K | $8.62 | 258.60K |
| 2025-05-29 | FAVORITO TAMARA A | Buy | 30.00K | $8.62 | 258.60K |
| 2025-05-29 | Watton Corey Michael | Buy | 30.00K | $8.62 | 258.60K |
| 2025-05-29 | Bode John B | Buy | 30.00K | $8.62 | 258.60K |
| 2025-05-29 | Anderson Thomas | Buy | 30.00K | $8.62 | 258.60K |
| 2025-03-28 | Watton Corey Michael | Buy | 300 | $7.84 | 2.35K |
| 2025-03-19 | Bode John B | Buy | 10.00K | $7.96 | 79.62K |
| 2025-02-14 | McFarlane Neil F. | Sell | 30.54K | $8.05 | 245.96K |
| 2025-02-13 | Sangiovanni Timothy J. | Sell | 3.00K | $7.86 | 23.59K |
| 2025-02-13 | Schafer Joshua | Sell | 10.50K | $7.86 | 82.53K |
| 2025-02-13 | Clifton R. LaDuane | Sell | 11.00K | $7.86 | 86.47K |
| 2025-02-13 | McFarlane Neil F. | Sell | 61.27K | $7.86 | 481.43K |
| 2025-02-07 | McFarlane Neil F. | Buy | 225.00K | $7.77 | 1.75M |
| 2025-02-07 | McFarlane Neil F. | Buy | 112.50K | — | — |
| 2025-01-31 | Sangiovanni Timothy J. | Sell | 11.67K | — | — |
| 2025-01-31 | Sangiovanni Timothy J. | Buy | 11.67K | — | — |
| 2025-01-31 | Schafer Joshua | Sell | 35.33K | — | — |
| 2025-01-31 | Schafer Joshua | Buy | 35.33K | — | — |
| 2025-01-31 | Clifton R. LaDuane | Sell | 43.33K | — | — |
| 2025-01-31 | Clifton R. LaDuane | Buy | 43.33K | — | — |
| 2025-01-31 | McFarlane Neil F. | Sell | 233.33K | — | — |
| 2025-01-31 | McFarlane Neil F. | Buy | 233.33K | — | — |
| 2025-01-30 | Quartel Adrian W | Buy | 68.00K | $8.02 | 545.36K |
| 2025-01-30 | Quartel Adrian W | Buy | 34.00K | — | — |
| 2025-01-30 | Sangiovanni Timothy J. | Buy | 38.00K | $8.02 | 304.76K |
| 2025-01-30 | Sangiovanni Timothy J. | Buy | 19.00K | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 168, holders +10 vs prior quarter. Ownership 77.06%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 5.11M | 652.39K | +14.64% | 73.26M |
| FMR LLC | 4.92M | 1.70M | +53.05% | 70.49M |
| WOODLINE PARTNERS LP | 4.79M | 1.33M | +38.68% | 68.63M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.64M | 169.58K | +6.87% | 37.84M |
| CAPTION MANAGEMENT, LLC | 2.00M | 1.91M | +2005.99% | 28.72M |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.80M | -724.46K | -28.73% | 25.78M |
| STATE STREET CORP | 1.68M | 120.43K | +7.71% | 24.12M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.54M | 169.08K | +12.32% | 22.10M |
| D. E. SHAW & CO., INC. | 1.31M | 460.49K | +54.40% | 18.74M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.24M | 399.02K | +47.37% | 17.80M |
| MORGAN STANLEY | 1.20M | 11.61K | +0.97% | 17.26M |
| LEGAL & GENERAL GROUP PLC | 1.20M | 38.58K | +3.32% | 17.23M |
| DIMENSIONAL FUND ADVISORS LP | 958.84K | 404.03K | +72.82% | 13.75M |
| ROYCE & ASSOCIATES LP | 882.66K | -106.02K | -10.72% | 12.66M |
| 683 CAPITAL MANAGEMENT, LLC | 855.00K | -120.00K | -12.31% | 12.26M |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 775.00K | 0 | 0.00% | 11.11M |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 634.41K | -16.74K | -2.57% | 9.10M |
| JUPITER TOPCO LLC | 613.40K | 613.40K | New | 8.80M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 597.16K | 597.16K | New | 8.56M |
| GOLDMAN SACHS GROUP INC | 545.55K | 521.95K | +2211.66% | 7.82M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 541.11K | 74.81K | +16.04% | 7.76M |
| NORTHERN TRUST CORP | 486.50K | 49.55K | +11.34% | 6.98M |
| SWEDBANK AB | 439.41K | 439.41K | New | 6.30M |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 439.33K | -66.70K | -13.18% | 6.15M |
| TUDOR INVESTMENT CORP ET AL | 415.06K | 282.36K | +212.78% | 5.95M |
Zevra Therapeutics, Inc. (ZVRA) trades at $10.16, with a market cap of $603.10M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$603.10M
Market Cap
—
P/E
—
Forward P/E
—
Score